ALA 2.78% 18.5¢ arovella therapeutics limited

Ann: Media Article, page-61

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. kcl
    331 Posts.
    lightbulb Created with Sketch. 134
    It doesn't make sense, does it?

    If its now .7 of a cent and there was a 1:10 consolidation the shares then should be 7 cents, but it never works out that way. I'm not a clinical psychologist but the market seems to perceive them as going from cheap to expensive.

    A not insubstantial number of traders/investors seem to pay little or no attention to market cap. The market cap should stay the same during a consolidation or a split. but it never does.

    With 2½ billion shares on issue a consolidation is inevitable eventually, but right now the potential for big percentage gains would be diminished.

    At the moment, shares are increasing (or decreasing I should point out) by .1 which is significantly more than 10% each time. With a consolidation of, say, 1:10, that .1 of a cent would be less than 2% so suddenly, with these tiny new steps, it all slows down.

    When big pharma pays us big cash they can consolidate as much as they want
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
18.5¢
Change
0.005(2.78%)
Mkt cap ! $195.4M
Open High Low Value Volume
18.5¢ 18.5¢ 18.0¢ $178.8K 968.8K

Buyers (Bids)

No. Vol. Price($)
1 3500 18.5¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 912626 8
View Market Depth
Last trade - 15.42pm 07/11/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.